Presentations on early-stage research and development companies working on approaches to address the unmet therapeutic needs in the Duchenne community.
We use cookies to ensure that we give you the best experience on our website. By continuing to use this site you are agreeing to accept our use of cookies. For more information about cookies please visit our Privacy Policy page.I Agree